What is one treatment option for normocytic anemia?

One treatment option for normocytic anemia is erythropoietin. Normocytic anemia is characterized by normal-sized red blood cells but with an overall decreased volume of red blood cells typically due to either inadequate production or increased destruction. Erythropoietin, a hormone produced primarily by the kidneys, stimulates the bone marrow to increase the production of red blood cells. This treatment is particularly effective in anemic patients with chronic kidney disease or certain cancers, where the body's ability to produce erythropoietin is compromised.

In cases where anemia is attributed to factors such as chronic disease or renal issues, using erythropoietin can lead to significant improvement by addressing the underlying deficiency in red blood cell production. This makes it a key intervention in the management of normocytic anemia in appropriate clinical situations.